High risk of bowel cancer for gene carriers
Researchers from the University of Melbourne have found that screening for bowel cancer in genetically high-risk populations should begin early.
Feb 4, 2015
0
31
Researchers from the University of Melbourne have found that screening for bowel cancer in genetically high-risk populations should begin early.
Feb 4, 2015
0
31
People with persistent heartburn are being urged to visit their GP as it may be a sign of cancer, according to a new campaign by Public Health England (PHE).
Jan 28, 2015
0
5
(HealthDay)—U.S. Food and Drug Administration approval of the anti-cancer drug Cyramza (ramucirumab) has been expanded to include aggressive non-small-cell lung cancer (NSCLC), the agency said Friday.
Dec 14, 2014
0
0
Patients with a specific type of oesophageal cancer survived longer when they were given the latest lung cancer drug, according to trial results being presented at the National Cancer Research Institute (NCRI) Cancer Conference ...
Nov 4, 2014
0
0
Researchers at the University of California, San Diego School of Medicine have, for the first time, clearly defined the epidemiology of gastrointestinal stromal tumors (GIST), which occur primarily in the lining of the stomach ...
Oct 7, 2014
0
0
A*STAR researchers show that changes in histone modifications accelerate a type of stomach tumor known as gastric adenocarcinoma—a cancer that occurs more frequently in Asian populations than Western populations.
Sep 10, 2014
0
0
Amid continuing tales of global woe, Thursday morning's news carried one of those quirky 'fancy-that!' medical research stories that often captures the imagination, but which can inadvertently raise false hope in patients.
Aug 25, 2014
0
0
The salt content of cheese sold in UK supermarkets remains high, despite many products meeting the recommended government targets on salt reduction, finds research published in the online journal BMJ Open.
Aug 6, 2014
2
0
A team of scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) discovered that a protein named IL23A is part of our stomach's defence against bacterial infection ...
Jul 4, 2014
0
0
(HealthDay)—Cyramza (ramucirumab) has been approved by the U.S. Food and Drug Administration to treat cancer of the stomach or of the area where the esophagus joins the stomach (the gastroesophageal junction).
Apr 22, 2014
0
0